Home » Reports » Broker Ratings » AstraZeneca plc 9.2% Potential Upside Indicated by Deutsche Bank
broker ratings

AstraZeneca plc 9.2% Potential Upside Indicated by Deutsche Bank

AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at Deutsche Bank. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set a target price of 6500 GBX on its stock. This is indicating the analyst believes there is a potential upside of 9.2% from the opening price of 5950 GBX. Over the last 30 and 90 trading days the company share price has increased 298 points and increased 372 points respectively. The 52 week high share price is 6126.4 GBX while the 52 week low for the stock is 4544.5 GBX.

AstraZeneca plc has a 50 day moving average of 5,856.51 GBX and a 200 day moving average of 5,341.79. There are currently 1,266,784,907 shares in issue with the average daily volume traded being 2,358,045. Market capitalisation for LON:AZN is £74,789,967,752 GBP.